Author Archive: Jeremy Parkinson
EC The Evaluation Of Common Stocks
“Stocks are not always worth what they sell for. Sometimes they are carried too high, sometimes too low, by mass excitement. Sooner or later, though, they move into line with value.” Arnold Bernhard I have met many financially secure families over the years. Most earned this financial security by working hard, while saving as much […]
Learning From Mistakes Made By Pension Funds
Forbes took a look at How Pension Funds Make Investing Too Complex. The issue was hedge funds and private equity funds that tend to be expensive, opaque or both. These types of direct investments also tend to be illiquid in terms of having long waiting periods before investors can get their money out. The Iowa Public […]
Market Commentary: Higher Open Bouncing Up From Yesterday’s Poor Performance
Written by Gary Gary is off , and the market open comes from our syndication partner Investing.com. U.S. stocks inched up at the open on Tuesday as a pair of big M&A deals boosted market optimism a day after the S&P 500’s worst performance in a month. The Dow Jones industrial average (DJI) rose 24.71 points, or […]
VIX (Fear Index) – Lowest Yearly Average Since 2006
CLICK ON CHART TO ENLARGE When it comes to investors fearing the stock market, this year won’t set any records for “excess fear.” The above table highlights annual averages for the VIX (Fear Index) over the past 24 years. The VIX index has hovered (on average) at low levels this year, the lowest average since […]
The Q Ratio And Market Valuation: Monthly Update
Note from dshort: Here is my monthly update with extrapolated data since the most recent Fed Z.1 report (through Q2). However, I’ll post a new update on December 11th, an hour or two after the Federal Reserve’s noon release of the Q3 Z.1 release. The Q Ratio is a popular method of estimating the fair value […]
Otsuka Pharmaceutical To Acquire Avanir Pharmaceuticals
TOKYO–(BUSINESS WIRE)–Otsuka Pharmaceutical Co., Ltd. is pleased to announce an agreement with Avanir Pharmaceuticals, Inc.(AVNR) (“Avanir”) in which Otsuka America, Inc., a US subsidiary, acquires Avanir for USD 3.5 billion in an all-cash tender offer. The contract was signed on December 2, Japan time. Avanir Pharmaceuticals Avanir is a biopharmaceutical company specializing in CNS diseases. […]
E Large Cap Best And Worst Report – December 2, 2014
Since 2010, our top scoring weekly has outpaced the SPX by a median 376 bps in the following year. The best performers from our list one year ago are RCL up 74%, FB up 65%, MU up 65%, AAPL up 50%, and HPQ up 45%. The best large cap sector is healthcare The top large […]
E Interview With CEO Of American Sands Energy
The following interview of Mr. William Gibbs was conducted by phone and email on November 28-29. Mr. Gibbs is CEO of American Sands Energy, [AMSE] an unconventional oil producer proposing to extract oil sands in Utah. The company expects to be in production of up to 9,000 barrels of oil per day within 2-3 years. Please give readers […]
The Dollar Comes Back Bid
After yielding ground yesterday, the US dollar comes back bid today. The main driver is the divergence that favors the US. Specifically, yesterday two people we have identified as part of the troika at the Federal Reserve, from where policy signals emanate, played down the disinflationary threat of the fall in oil, saying it would likely […]
